Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy

Hematol J. 2004;5(5):453-5. doi: 10.1038/sj.thj.6200405.
No abstract available

Publication types

  • Evaluation Study
  • Letter
  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / epidemiology*
  • Brain Neoplasms / radiotherapy
  • Combined Modality Therapy
  • Cranial Irradiation
  • Cyclophosphamide / administration & dosage
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / pharmacokinetics
  • Immunocompetence
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / epidemiology
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Middle Aged
  • Prednisolone / administration & dosage
  • Remission Induction
  • Retrospective Studies
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Cyclophosphamide
  • Prednisolone
  • Idarubicin

Supplementary concepts

  • CIOP protocol